August 11th 2025
NRx Pharmaceuticals secures FDA Fast Track designation for NRX-100, a preservation-free formulation of intravenous ketamine for suicidal ideation in depression.
The extent to which antidepressant use during pregnancy is associated with increased risks of postnatal adaptation syndrome, persistent pulmonary hypertension in the newborn, first-trimester teratogenicity, stillbirth, and infant mortality is explored in 2 recent studies. A close up look here. . .
Read More
Diagnosis and its Discontents: The DSM Debate Continues
March 29th 2013When critics of psychiatric diagnosis insist that terms like “schizophrenia” or “bipolar disorder” are inherently stigmatizing, they are unwittingly perpetuating the very prejudice they wish to end. It is time to shine a bright light on this self-fulfilling prophecy.
Read More
How Frame Analysis Can Guide the Therapeutic Process
March 18th 2013Frame analysis can not only help us to discern the roots of such standoffs but also to conceptualize specific ways of addressing the conflicts in therapeutic language with the patient, with the goal of forging an integrated approach to treatment.
Read More
The Medicalization of Grief: What We Can Learn From 19th-Century Nervousness
March 2nd 2013Concerns are raised about DSM-5 revisions in the definition of depression. Many worry that eliminating the bereavement exception in the guidelines for the diagnosis of major depressive disorder represents a dangerous move.
Read More
Comorbidity In Psychiatric Disorders: A Literature Review
January 19th 2013A list of recent articles highlighting the complexity of psychiatric and systemic illness, both in terms of overlapping clinical presentation and in the degrees to which systemic illness and psychiatric illness affect each other.
Read More